Atlas Trials

Clinical Study of YS110 in Patients With Malignant Pleural Mesothelioma

Clinical trial NCT03177668 · COMPLETED

Trial details

NCT number
NCT03177668
Sponsor
Kissei Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Malignant Pleural Mesothelioma
Start date
2017-08-08
Primary completion
2020-02-05
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.